Virtual Reality Experiences for Anxiety and Pain Control

NCT ID: NCT04759183

Last Updated: 2022-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-05

Study Completion Date

2022-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial studies the impact of virtual reality experiences on anxiety before surgery and pain after surgery. The goal of this study is to examine how different virtual reality experiences may help reduce anxiety and improve pain control, which may help reduce the need for medications such as opioids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. To measure the impact of a gaming virtual reality (VR) experience compared to a mindfulness VR experience on preoperative anxiety and postoperative pain.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients participate in a VR intervention (Angry Birds) over 15 minutes before standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes after surgery.

ARM II: Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (Angry Birds, TRIPP)

Patients participate in a VR intervention (Angry Birds) over 15 minutes before standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes after surgery.

Group Type EXPERIMENTAL

Survey Administration

Intervention Type OTHER

Ancillary studies

Virtual Reality Game

Intervention Type PROCEDURE

Participate in VR Game "Angry Birds"

Virtual Reality Meditation

Intervention Type PROCEDURE

Participate in VR Meditation "TRIPP"

Arm II (TRIPP, Angry Birds)

Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after surgery.

Group Type EXPERIMENTAL

Survey Administration

Intervention Type OTHER

Ancillary studies

Virtual Reality Game

Intervention Type PROCEDURE

Participate in VR Game "Angry Birds"

Virtual Reality Meditation

Intervention Type PROCEDURE

Participate in VR Meditation "TRIPP"

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey Administration

Ancillary studies

Intervention Type OTHER

Virtual Reality Game

Participate in VR Game "Angry Birds"

Intervention Type PROCEDURE

Virtual Reality Meditation

Participate in VR Meditation "TRIPP"

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VR Game VR Meditation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (18 years or older and younger than 89)
* Able to consent
* English-speaking

Exclusion Criteria

* Non-English speaking patients because the VR content is only available in English
* Have symptoms concerning for an active respiratory infection or are on contact or isolation precautions
* Any active eye discharge
* A history of seizure, epilepsy, or hypersensitivity to flashing light
* Have a history of motion sickness or vertigo
* Have active nausea or vomiting
* Psychiatric conditions that may interfere with the ability to successfully participate in the study
* Have cardiac pacemakers
* Require hearing aids at all times that cannot be removed
* Have defibrillators
* Have wound dressings on the head or neck that prevent comfortable use of the VR headset
Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oregon Health and Science University

OTHER

Sponsor Role collaborator

OHSU Knight Cancer Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ryan Li, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ryan J Li

Role: PRINCIPAL_INVESTIGATOR

OHSU Knight Cancer Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

OHSU Knight Cancer Institute

Portland, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2021-00794

Identifier Type: REGISTRY

Identifier Source: secondary_id

STUDY00022194

Identifier Type: OTHER

Identifier Source: secondary_id

STUDY00022194

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Virtual Reality and Pain
NCT04351776 COMPLETED NA
Firsthand ID for Pain Control
NCT01823874 COMPLETED NA